Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a sedative make IUD insertion less painful? study pulled before it began

NCT ID NCT06496854

Symptom relief Sponsor: University of Wisconsin, Madison Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study aimed to see if giving lorazepam, a sedative, before IUD insertion could reduce pain and anxiety. It planned to enroll 25 adults at a family medicine clinic. However, the study was withdrawn before any participants were enrolled, so no data was collected.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
lorazepam
What this could lead to
If it works, this could point toward a way to ease anxiety and pain during IUD insertion for some people.
What could go wrong
This study was withdrawn before enrolling anyone, so no results exist. It was a tiny pilot with only 25 planned participants, so even if done, findings might not apply broadly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Expected to start

Oct 2025

An estimate. Start dates often move.

Expected to finish

Jan 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants who undergo IUD insertion and complete the visual analogue scales to rate their anxiety and pain level prior to the procedure and after the procedure. * Participants must have a driver take them to their appointment if they take lorazepam prior to their arrival at the clinic. * Participants must have a driver take them home after the procedure as well. * Participants must consent to email communication since they will sign the consent forms electronically Exclusion Criteria: * Participants who do not show up for their appointment. * Participants who receive cervical blocks or other analgesic method during IUD insertion. * Participants who have a history of substance use disorder. * Participants who are taking medications with a central nervous system (CNS) depressant effect (ex: opioids, benzodiazepines). * Participants who are not able to sign an electronic consent form. * Participants who do not have a driver to take them to their appointment and to take them home after the procedure. * Participants who do not agree to sign consent forms electronically.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IUD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IUD Pain

Contacts and locations

Locations

  • UW Family Medicine Residency Clinics

    Madison, Wisconsin, 53715, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.